Search the web
Welcome, Guest
[Sign Out, My Account]

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
AEGR > SEC Filings for AEGR > Form 8-K on 25-Jun-2013All Recent SEC Filings




Entry into a Material Definitive Agreement

Item 1.01. Entry into a Material Definitive Agreement.

On June 19, 2013, Aegerion Pharmaceuticals, Inc. (the "Company") entered into a Third Amendment to Lease (the "Lease Amendment"), by and between the Company and RREEF America REIT II Corp. PPP (the "Landlord"), which amends the Lease dated January 1, 2011, by and between the Company and the Landlord, as such lease has been amended from time to time (as so amended, the "Original Lease," and together with the Lease Amendment, the "Lease"). Under the Lease Amendment, the Company has leased 7,350 square feet of additional space for its headquarters in Cambridge, Massachusetts and extended the term for all of the leased space covered by the Lease through August 31, 2017. Under the terms of the Lease, the base rent, subject to certain adjustments, for all of the leased space covered by the Lease will be $96,521.83 per month, plus certain operating expenses and taxes, and shall increase on an annual basis and otherwise as provided in the Lease.

The foregoing description of the terms of the Lease, including the Lease Amendment, does not purport to be complete and is qualified in its entirety by reference to the full text of the Original Lease, including all prior amendments thereto, which have been filed previously by the Company, and the Lease Amendment, a copy of which will be filed with the Company's Quarterly Report on Form 10-Q for the period ending on June 30, 2013.

  Add AEGR to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for AEGR - All Recent SEC Filings
Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.